This multi-disciplinary webinar series aims to provide a broader view of best practice and recent developments in the health, care and protection space, and of current mortality research in a variety of relevant fields, informing your practice and continuing professional development.
Webinar recordings can now be accessed from the Online learning resources page.
This series will be of value to anyone concerned with setting or reviewing mortality and longevity assumptions, discovering how innovation, technological and medical advances are impacting on the design and launch of new products in the health or protection space, learning from international experience, or with an interest in better understanding and projecting mortality and longevity.
- Relevant to actuaries in life, health, and pensions fields
- Insurance professionals such as underwriters, product designers and data scientists
- Academics and researchers in medical and actuarial fields, epidemiologists, policy-makers and gerontologists
- Those with an interest in mortality and longevity, protection, health and care business, and new product development.
Webinars can be booked individually. Simply click on the ‘book now’ link above to be taken to the webinar series booking platform, where you can select which webinars you wish to view.
Contact Events Team for more information.
0207 632 1498
Tuesday 4 June
Introduction to the programme
Speakers: Sacha Dhamani, Prudential Assurance (Symposium Chair) and Zoe Woodroffe, Gen Re (Conference Chair)
Speakers: Cobus Daneel, Dave Grimshaw and Matt Fletcher, CMI
Marriage matters: a practical guide to modelling contingent dependants
With interest rates at historic lows, dependant proportions and age difference are increasingly material to pension liability calculations, with spreads of up to 6% in total liability value between the most and least affluent groups of pensioners. They have also become a growing focus for longevity swap and bulk annuity transactions and can be a key driver of price differentials.
This session offers a practical tour of the latest modelling techniques, including
-survey non-respondent bias and how to deal with it,
-tracing accuracy and interpretation of codes, and
-allowing for trends by age/gender, time and socio-economic profile.
Speaker: Andy Harding, Aon
Drug Innovation and longevity
The talk will argue trends in drug innovation in recent decades have had an underestimated causal impact on longevity improvements over the same time period. This includes the slowdown in longevity gains since the start of this decade and, in particular, the associated decline in the rate of cardiovascular related mortality improvements. The talk will also argue these same trends in drug innovation offer a plausible guide to future decades’ longevity trends – including the prospects of disease-modifying drugs for dementia related illnesses.
Speaker: Ivor O’Shea
Trends in the cause-specific mortality experience in England and Wales
In recent years, the improvement in all-cause mortality rates has been slowing down in England and Wales. By analysing the cause-specific mortality rates, we investigate major causes for the observed slowdown.
We use generalised linear models to model death counts in the all-cause and cause-specific mortality experience in England and Wales from 2001 to 2017. Breakpoint analysis techniques are employed for the purposes of identifying and quantifying the changes in all-cause and cause-specific mortality trends. We also address the effect of the change in cause-of-death classifications on the cause-specific mortality rates in England and Wales.
Speakers: Alexander Yiu, Heriot-Watt University
10 longevity insights that I wish I'd known sooner
In the midst of the daily hustle and bustle, it pays to occasionally take stock, and look back at how far we've come.
Drawing on analysis from Club Vita's first 10 years, as well as other sources, I will explore 10 of the most interesting insights from the world of pension scheme longevity, including some old favourites, such as:
-the key drivers of longevity;
-variations between pension schemes.
A few perhaps less well known topics, such as:
-some intriguing demographic features;
-exploring non-pensioner experience;
-scenarios for future improvements; and
-a look overseas.
Speaker: Conor O'Reilly, Club Vita
Longevity trend risk over limited time horizons
Solvency II regulations in the EU, and similar regulations elsewhere, specify a one-year, value-at-risk (VaR) approach to solvency assessment. However, there are other horizons besides one year where a value-at-risk assessment of longevity trend risk is useful. One example is the 3-5 year horizon for a Pillar II ORSA requirement of Solvency II, another is for pension schemes aiming to achieve a level of funding for a buy-out and a third is the payout of an index-based longevity hedge. This presentation looks at n-year VaR and CTE assessments of longevity trend risk for these use-case scenarios, and contrasts the results with the usual one-year view. We consider the longevity risk in both deferred and immediate annuities.
Speaker:Stephen Richards, Longevitas
Wednesday 5 June
Waste not – Calibrating mortality models using all information
The common approach to calibrating stochastic age-period-cohort (APC) models is to decompose the data into various APC components, choose which components to model and finally to fit ARIMA processes to them. This unfortunately discards information on the uncertainty of the observations and obscures both identifiability issues and the common aspects of smoothing and fitting ARIMA processes.
We present a new approach that
Speaker: Tim Gordon, Aon
Launching an impaired life proposition in 10 weeks
On 7 September 2017, Just Retirement announced they would withdraw from the impaired lives market. Less than 10 weeks later, The Exeter wrote its first impaired life case. The talk will cover
Speaker: John Gunn, The Exeter
Population Health Management Working Party
Population Health Management considers the distribution of health outcomes within a population and how to impact these outcomes in the most optimal way for the group as a whole. The Working Party will initially focus on the specific topic of impactability modelling, an area where actuarial skills can help bring insight to some of the strategic challenges the NHS is facing. This session will provide an update on the working party's research including defining impactability, understanding different modelling approaches, considering the practical challenges across the NHS as well as wider public perception and ethical issues.
Alpesh Shah, PwC,
David Beddows, Optum,
Joanne Buckle, Milliman
Chris Martin, Crystallise
Sarah Culkin, NHS England
Antibiotic Resistance Working Party
Antibiotic resistance has been of increasing concern to health professionals, with the potential for millions of extra deaths worldwide. In this session, the ABR WP presents the conclusions of its two-year study. The presentation covers a medical/biological overview, ABR modelling considerations, our results (including comparisons v HIV and insurer cat risk stresses), and an introduction to the model (available through the IFOA website). The conclusions will be of interest from both mortality and longevity perspectives. Presentation would be similar to the 25 Feb sessional paper event (Edinburgh).
Speakers: Matthew Edwards, Willis Towers Watson and Nicola Oliver, Medical Intelligence
Developments in mental health underwriting
Mental health problems are highlighted as a significant cause of distress and loss of productivity in the workplace.
Understanding the nature and consequences of psychological distress can be difficult during underwriting. Changing perceptions of risk have not always been incorporated into insurance practice. This has led to high profile public comments about the perception of unfair treatment of those with mental health problems in accessing insurance products.
Fair treatment of the customer is a fundamental plank of financial services regulation and this workshop explores some of the issues in developing an understanding and the practical steps to address the issue.
Speakers: Chris Ball and Lynn Timmons, Gen Re
Thursday 6 June
Access, exclusion and trust in insurance
Charities, consumer groups, politicians, financial advisers, consumer journalists and our regulator are increasingly commenting on the difficulties that consumers with specific insurance needs are facing when trying to access cover, especially when using mass market distribution channels. Consumers unable to access meaningful information about or signposting too alternative providers of insurance, or lower-cost policies, can and increasingly do assume they are uninsurable or cannot afford cover, so excluding them from the market. This risks causing significant harm to the reputation of our industry and profession, additionally it brings into question the social purpose of insurance.
In this session, Johnny Timpson in his capacity as DWP Disability Champion for our Industry and Profession will discuss;
Speaker: Johnny Timpson, Scottish Widows
Identifying avoidable admissions using international benchmarks
Traditionally, differences in international coding have made producing risk-adjusted international benchmarks challenging. Using over 10 million life-years of data, we compare the UK PMI market to our International Best Practice Benchmarks. These allow us to classify a healthcare system by its degree of healthcare-management, which reflects a system’s compliance to evidence-based-care guidelines, access/restriction to services and use of incentives. We compare this to well/loosely managed benchmarks to identify activity levels that are challenging yet achievable with optimal infrastructure. We also touch upon results from further advanced analytics including:
Speakers: Natasha Singhal and Tanya Hayward, Milliman
Critical Illness: A tale of three continents
This presentation will look at critical illness across international markets, from the UK to Canada, from Eastern Europe to Israel and across Canada. Past and potential future product evolution will be covered by speakers from three key markets. Pricing considerations and claims experience will be compared and contrasted.
Speakers: Aisling Kennedy, Swiss Re Services and Hengchang Pan, Swiss Re
Driven by the desire to act fairly toward policyholders as health deteriorates with age, we have developed a business model where we underwrite someone just once at the outset of the policy.
Do we miss the opportunity to assess more accurately modifiable risks over time, price our products more fairly and allow those who take positive action to improve their health to benefit directly from their efforts.
Does it make sense that we assess health only once during the policy lifetime given the impact individuals have on their health from decisions they make about their diet, exercise and lifestyle?
Speaker:Alan Martin, Swiss Re
Nearest Public Transport
This is a webinar event